The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 27, 2012
Filed:
Dec. 27, 2005
Kyu Yang Yi, Taejeon-si, KR;
Sunkyung Lee, Taejeon-si, KR;
Jee Hee Suh, Taejeon-si, KR;
Nak Jeong Kim, Taejeon-si, KR;
Hyunsuk Lee, Chungcheongnam-do, KR;
Byung-ho Lee, Taejeon-si, KR;
Sung-eun Yoo, Kongju-si, KR;
Kyung-hee Lee, Sungnam-si, KR;
Yong OH Lee, Koyang-si, KR;
Kyu Yang Yi, Taejeon-si, KR;
SunKyung Lee, Taejeon-si, KR;
Jee Hee Suh, Taejeon-si, KR;
Nak Jeong Kim, Taejeon-si, KR;
Hyunsuk Lee, Chungcheongnam-do, KR;
Byung-Ho Lee, Taejeon-si, KR;
Sung-eun Yoo, Kongju-si, KR;
Kyung-Hee Lee, Sungnam-si, KR;
Yong Oh Lee, Koyang-si, KR;
Korea Research Institute of Chemical Technology, Taejeon-si, KR;
Abstract
The present invention is related to benzothiophen-2-carbonylguanidine derivatives, a preparation method thereof, and pharmaceutical compositions containing the same. The derivatives have potent inhibitory effect on the sodium/hydrogen exchanger NHE-I, improve the functional recovery of ischemia/reperfusion-induced heart injury in isolated ischemic heart models, and significantly reduce the myocardiac infarct size in in vivo ischemic animal models, thereby showing excellent cardioprotective effects. Also, the derivatives are protective of both neuronal cells and the brain as proven by their protective effects on neuronal cells from necrosis and apoptosis and by their ability to significantly reduce cerebral infarct sizes in in vivo ischemic brain models. The derivatives can be effectively used for the prevention and treatment of ischemic heart diseases such as myocardiac infarction, arrhythmia, angina pectoris and the like, and cerebrovascular diseases such as cerebral stroke and be used as cardioprotective agents to the patients undergoing reperfusion therapy including chemicals such as thrombolytic agents, or surgery such as coronary artery bypass and percutaneous transluminal coronary angioplasty.